Although both adiponectin and leptin levels have the potential to be biomarkers for predicting metabolic syndrome (41, 72–74), recent studies have suggested leptin/adiponectin ratio (L/A ratio) as a stronger candidate as compared with adiponectin and leptin alone (27, 73). The gene discussed is LEP; the disease is metabolic syndrome.